For 2023, the company continues to see sales growth of 6%-8% to $3.66 billion- $3.73 billion versus the consensus of $3.7 billion.

For Q2 2023, THS reaffirmed guidance for revenue at $810 million-$840 million (consensus: $830.46 million), an adjusted EBITDA margin of 7.9%-9.4% (representing 130 to 280 basis points YoY), and adjusted EBITDA of $65 million-$80 million. 

At the investor day, THS will offer insights into the annual growth targets for 2024-2027, which includes revenue growth of 3%-5%, adjusted EBITDA growth of 8%-10%, and FCF of over 200 million.

THS expects to achieve cost savings of over $250 million from 2024 to 2027, led by investments related to supply chain optimization.

Last month, the company reported first-quarter sales growth of 15.8% year-over-year to $894.8 million, beating the consensus estimate of $850.84 million and adjusted EPS of $0.68, exceeding the consensus estimate of $0.40.

Price Action: THS shares are trading higher by 5.47% at $54.00 premarket on the last check Tuesday.